Abstract | BACKGROUND/AIMS: METHODS: Here, we evaluated the effects of RBPJ inhibition on the growth of prostate cancer cells. We knocked down RBPJ in prostate cancer cells by a short hairpin interfering RNA ( shRNA). We measured cell growth by an MTT assay. We analyzed the levels of cell-cycle-associated proteins by Western blot. RESULTS: We found that shRNA for RBPJ efficiently inhibited RBPJ expression in prostate cancer cells, resulting in a significant decrease in the cell growth. Further, RBPJ-mediated cell-growth inhibition appeared to be resulting from alteration of cell-cycle inhibitors p21 and p27, cell-cycle activators CDK2, CDK4 and CyclinD1, and apoptosis-suppressor Bcl-2. CONCLUSION: Our data suggest that shRNA intervention of RBPJ expression could be a promising therapeutic approach for treating human prostate cancer.
|
Authors | Li Xue, Hecheng Li, Qi Chen, Zhenlong Wang, Peng Zhang, Haiwen Chen, Ziming Wang, Tie Chong |
Journal | Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
(Cell Physiol Biochem)
Vol. 36
Issue 5
Pg. 1982-90
( 2015)
ISSN: 1421-9778 [Electronic] Germany |
PMID | 26202358
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2015 S. Karger AG, Basel. |
Chemical References |
- Immunoglobulin J Recombination Signal Sequence-Binding Protein
- RBPJ protein, human
- RNA, Small Interfering
|
Topics |
- Cell Line, Tumor
- Cell Proliferation
(genetics)
- HEK293 Cells
- Humans
- Immunoglobulin J Recombination Signal Sequence-Binding Protein
(genetics)
- Male
- Prostatic Neoplasms
(genetics, pathology)
- RNA, Small Interfering
(genetics)
|